Association of interleukin 1 gene family polymorphisms with duodenal ulcer disease

Clinical and Experimental Immunology

Volumn 134, Issue 3, 2003, Pages 525-531

  Garcia Gonzalez, M A ^a   Lanas, A ^a   Savelkoul, P H M ^b   Santolaria, S ^c   Benito, R ^d   Crusius, J B A ^b   Pena A S ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HOSPITAL SAN JORGE   (Spain)

^d UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Cytokine; Duodenal ulcer; Helicobacter pylori; NSAIDs; Polymorphism

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG USE; DUODENUM ULCER; FAMILY HISTORY; FEMALE; GENDER; GENETIC PREDISPOSITION; GENOTYPE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOMODULATION; MAJOR CLINICAL STUDY; MALE; MULTIGENE FAMILY; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING HABIT; SPAIN; STOMACH ACID SECRETION; VARIABLE NUMBER OF TANDEM REPEAT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DUODENAL ULCER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTERLEUKIN-1; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-1; RISK FACTORS;

EID: 0346751947     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2003.02325.x     Document Type: Article

References (52)

1. Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270:17771-7.
2. Orsini B, Ciancio G, Censini S et al. Helicobacter pylori cag pathogenicity island is associated with enhanced interleukin-8 expression in human gastric mucosa. Dig Liver Dis 2000; 32:458-67.
3. Israel DA, Salama N, Arnold CN et al. Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responses. J Clin Invest 2001; 107:611-20.
4. Tham KT, Peek RM Jr, Atherton JC et al. Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease. Hum Pathol 2001; 32:264-73.
5. Nomura AM, Perez-Perez GI, Lee J, Stemmermann G, Blaser MJ. Relation between Helicobacter pylori cagA status and risk of peptic ulcer disease. Am J Epidemiol 2002; 155:1054-9.
6. Atherton JC. H. pylori virulence factors. Br Med Bull 1998; 54:105-20.
7. Perez-Perez GI, Peek RM, Legath AJ, Heine PR, Graff LB. The role of CagA status in gastric and extragastric complications of Helicobacter pylori. J Physiol Pharmacol 1999; 50:833-45.
8. Graham DY, Yamaoka Y. Disease-specific Helicobacter pylori virulence factors: the unfulfilled promise. Helicobacter 2000; 5:S3-9.
9. Enroth H, Kraaz W, Engstrand L, Nyren O, Rohan T. Helicobacter pylori strain types and risk of gastric cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 2000; 9:981-5.
10. Uehara A, Namiki M. Immunopathology of ulcer disease. Ann NY Acad Sci 1993; 697:260-8.
11. Ernst PB, Jin Y, Reyes VE, Crowe SE. The role of the local immune response in the pathogenesis of peptic ulcer formation. Scand J Gastroenterol Suppl 1994; 205:22-8.
12. Cover TL. Helicobacter pylori transmission, host factors, and bacterial factors. Gastroenterology 1997; 113:S29-S30.
13. Dinarello CA. Interleukin-1. Rev Infect Dis 1984; 6:51-95.
14. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN. Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 1994; 29:425-9.
15. Lindholm C, Quiding-Jarbrink M, Lonroth H, Hamlet A, Svennerholm AM. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1998; 66:5964-71.
16. Robert A, Saperas E, Zhang WR et al. Gastric cytoprotection by intracisternal interleukin-1 beta in the rat. Biochem Biophys Res Commun 1991; 174:1117-24.
17. Robert A, Olafsson AS, Lancaster C, Zhang WR. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach, and retards gastric emptying. Life Sci 1991; 48:123-34.
18. Serrano MT, Lanas AI, Lorente S, Sainz R. Cytokine effects on pepsinogen secretion from human peptic cells. Gut 1997; 40:42-8.
19. Beales IL, Calam J. Interleukin 1 beta and tumour necrosis factor alpha inhibit acid secretion in cultured rabbit parietal cells by multiple pathways. Gut 1998; 42:227-34.
20. Takashima M, Furuta T, Hanai H, Sugimura H, Kaneko E. Effects of Helicobacter pylori infection on gastric acid secretion and serum gastrin levels in Mongolian gerbils. Gut 2001; 48:765-73.
21. Uehara A, Okumura T, Sekiya C, Okamura K, Takasugi Y, Namiki M. Interleukin-1 inhibits the secretion of gastric acid in rats, possible involvement of prostaglandin. Biochem Biophys Res Commun 1989; 162:1578-84.
22. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994; 106:533-9.
23. Nicklin MJ, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-1 alpha, interleukin-1 beta, and interleukin-1 receptor antagonist genes. Genomics 1994; 19:382-4.
24. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A. Duff GW. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91:403-4.
25. di Giovine FS, Takhsh E, Blakemore AI, Duff GW. Single base polymorphism at -511 in the human interleukin-1 beta gene (IL1 beta). Hum Mol Genet 1992; 1:450.
26. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A TaqI polymorphism in the human interleukin-1 beta (IL-1 beta) gene correlates with IL-1 beta secretion in vitro. Eur J Clin Invest 1992; 22:396-402.
27. Danis VA, Millington M, Hyland VJ, Grennan D. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99:303-10.
28. Andus T, Daig R, Vogl D et al. Imbalance of the interleukin 1 system in colonic mucosa - association with intestinal inflammation and interleukin 1 receptor antagonist genotype 2. Gut 1997; 41:651-7.
29. Tountas NA, Casini-Raggi V, Yang H et al. Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology 1999; 117:806-13.
30. Schrijver HM, Crusius JB, Uitdehaag BM et al. Association of interleukin-1beta and interleukin-1 receptor antagonist genes with disease severity in MS. Neurology 1999; 52:595-9.
31. Kantarci OH, Atkinson EJ, Hebrink DD, McMurray CT, Weinshenker BG. Association of two variants in IL-1beta and IL-1 receptor antagonist genes with multiple sclerosis. J Neuroimmunol 2000; 106:220-7.
32. Mansfield JC, Holden H, Tarlow JK et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106:637-42.
33. Bioque G, Crusius JB, Koutroubakis I et al. Allelic polymorphism in IL-1 beta and IL-1 receptor antagonist (IL-1Ra) genes in inflammatory bowel disease. Clin Exp Immunol 1995; 102:379-83.
34. Buchs N, di Giovine FS, Silvestri T, Vannier E, Duff GW, Miossec P. IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levels. Genes Immun 2001; 2:222-8.
35. El-Omar EM, Carrington M, Chow W et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402.
36. Machado JC, Pharoah P, Sousa S et al. Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 2001; 121:823-9.
37. Garcia-Gonzalez MA, Lanas A, Santolaria S, Crusius JBA, Serrano MT, Pena AS. The polymorphic IL-1B and IL-1RN genes in the aetiopathogenesis of peptic ulcer. Clin Exp Immunol 2001; 125:368-75.
38. Lanas A, Fuentes J, Benito R, Serrano P, Bajador E, Sainz R. Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirine. Aliment Pharmacol Ther 2002; 16:779-86.
39. Santolaria S, Lanas A, Benito R, Perez-Aisa MA, Montoro M, Sainz R. Helicobacter pylori infection is a protective factor for bleeding gastric ulcers but not for bleeding duodenal ulcers in NSAID users. Aliment Pharmacol Ther 1999; 13:1511-8.
40. Lanas A, Sekar MC, Hirschowitz BI. Objective evidence of aspirin use in both ulcer and nonulcer upper and lower gastrointestinal bleeding. Gastroenterology 1992; 103:862-9.
41. Blin N, Stafford DW. A general method for isolation of high molecular weight DNA from eukaryotes. Nucl Acids Res 1976; 3:2303-8.
42. Tytgat GN. Duodenal ulcer disease. Eur J Gastroenterol Hepatol 1996; 8:829-33.
43. Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer. Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clin Gastroenterol 1997; 24:2-17.
44. Furuta T, El-Omar EM, Xiao F, Shirai N, Takashima M, Sugimurra H. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123:92-105.
45. Bioque G, Bouma G, Crusius JB et al. Evidence of genetic heterogeneity in IBD. 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis. Eur J Gastroenterol Hepatol 1996; 8:105-10.
46. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 1998; 28:2598-602.
47. Santtila S, Savinainen K, Hurme M. Presence of the IL-1RA allele; 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scand J Immunol 1998; 47:195-8.
48. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, Yamaoka Y. Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 2002; 123:1793-803.
49. van Doorn LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, de Boer W, Quint W. Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology 1998; 115:58-66.
50. Figueiredo C, Machado JC, Pharoah P et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002; 94:1680-7.
51. Morre S, Murillo L, Crusius JB et al. Relevance of the IL1B-511 and IL-1RN gene polymorphisms and their genotypes in peptic ulcer disease (PUD) and non-ulcer-dyspepsia (NUD) versus helicobacter pylori cagA subtype infection. Gastroenterology 2002; 122:A-209.
52. Lanas A, Garcia-Gonzalez MA, Santolaria S et al. TNF and LTA gene polymorphisms reveal different risk in gastric and duodenal ulcer patients. Genes Immun 2001; 2:415-21.